Cellnovo Group

Cellnovo Group is a medical technology company based in France that focuses on mobile systems for managing type 1 diabetes. Its flagship product, the Cellnovo System, is the first mobile, connected, all-in-one diabetes management system designed to enhance the lives of individuals with type 1 diabetes. The Cellnovo System features an insulin patch pump, an activity monitor, and a cellular-enabled wireless touchscreen handset with an embedded blood glucose meter. It provides automatic wireless connectivity for real-time data transmission, allowing for continuous remote monitoring by family members and healthcare professionals. This integration of technology ensures that patients can manage their diabetes effectively while enjoying greater freedom and peace of mind. The Cellnovo System has received CE Mark approval and is available in ten countries, including France, the UK, and Australia. The company aims to expand its commercialization efforts in Europe, the United States, and Asia, while increasing production to meet rising demand. Founded in 2002, Cellnovo Group went public on Euronext Paris in July 2015 and continues to focus on innovative diabetes management solutions.

• Employees 14
• Founded 2002
• Annual Revenue $1272000